Table 1 Correlation between the SNCG expression and clinicopathological characteristics in 312 patients with EOC
Characteristics | No. Patients | SNCG Expression | P value | |
|---|---|---|---|---|
(n = 312) | Low No. (%) | High No. (%) |  | |
Age(years) | ||||
  < 51.0 | 169 | 58 (34.3%) | 111 (65.7%) |  |
  ≥ 51.0 | 143 | 41 (28.7%) | 102 (71.3%) | 0.285 |
Ca125 (U/ml) | ||||
  < 105 | 53 | 26 (49.1%) | 27 (50.9%) |  |
  ≥ 105 | 259 | 73 (28.2%) | 186 (71.8%) | 0.003 |
FIGO stage | ||||
 I/II | 73 | 40 (54.8%) | 33 (45.2%) |  |
 III/IV | 239 | 59 (24.7%) | 180 (75.3%) | < 0.001 |
Grade | ||||
 1 | 58 | 26 (44.8%) | 32 (55.2%) |  |
 2/3 | 254 | 73 (28.7%) | 181 (71.3%) | 0.018 |
Histology | ||||
 Type I | 96 | 48 (50.0%) | 48 (50.0%) |  |
 Type II | 216 | 51 (23.6%) | 165 (76.4%) | < 0.001 |
Ascites | ||||
 Yes | 211 | 62 (29.4%) | 149 (70.6%) |  |
 No | 101 | 37 (36.6%) | 64 (63.4%) | 0.198 |
Cytoreductive surgery | ||||
 Optimal | 273 | 80 (29.3%) | 193 (70.7%) |  |
 Sub-optimal | 39 | 19 (48.7%) | 20 (51.3%) | 0.015 |